[Intravenous administration of molsidomin in the acute period of myocardial infarct].
A study of central hemodynamic parameters, ECG charting and the activity of serum CPK and its MB fraction in 58 patients with acute myocardial infarction demonstrated that intravenous administration of 20 mg Corvaton, at the rate of 3 micrograms/kg/min, was effective for both controlling an acute left-ventricular failure, and limiting the infarcted area. A three-day treatment normalized systemic and central hemodynamic parameters in cases of medium-size infarction, and considerably reduced manifestations of acute left-ventricular failure in patients with a large area of necrosis.
D006801:Humans; D007275:Injections, Intravenous; D008981:Molsidomine; D009203:Myocardial Infarction / Q000188:drug therapy*; D010069:Oxadiazoles / Q000627:therapeutic use*; D013558:Sydnones / Q000008:administration & dosage / Q000627:therapeutic use*
D010069:Oxadiazoles; D013558:Sydnones; D008981:Molsidomine
Vnutrivennoe primenenie molsidomina v ostrom periode infarkta miokarda.